SCHEMBL2905208

SCHEMBL2905208

C[C@H](CO)NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.42
GSK3A P49840 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CDK1 P06493 2/20 0.39
CCNB2 O95067 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
ALOX5AP P20292 3/20 0.35
FEN1 P39748 3/20 0.35
MAPK1 P28482 6/20 0.35
ACVR1B P36896 3/20 0.34
TGFBR1 P36897 3/20 0.34
ACVRL1 P37023 3/20 0.34
ACVR1 Q04771 1/20 0.34
DCAF1 Q9Y4B6 1/20 0.33
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912215 1.00 GSK3B (0.42) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL12892551 0.93 GSK3B (0.48) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2909689 0.93 ALOX5AP (0.36) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2910831 0.93 GSK3B (0.48) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2906814 0.93 ALOX5AP (0.36) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2904789 0.93 GSK3B (0.48) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2944754 0.91 ALOX5AP (0.35) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2905628 0.91 ALOX5AP (0.35) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2910067 0.91 GSK3B (0.47) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1
SCHEMBL2908086 0.91 GSK3B (0.47) GSK3BGSK3ASMN1; SMN2ALDH1A1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed